Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.
Wendy Allen-RhoadesPhilip J LupoMichael E ScheurerYueh-Yun ChiJohn F KutteschRajkumar VenkatramaniWilliam H MeyerLeo MascarenhasPublished in: Cancer medicine (2023)
These data support further investigation of vinorelbine in newly diagnosed patients with RMS particularly those with alveolar histology.